QView Medical Inc.
USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Qview ranks #37,151 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.
- #37,151
- of 49,997 US assignees by volume
- 32nd percentile
- by Innovation Score (29.7/100)
- 21.7
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R37151 · US Corporation #37,151 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #37,151/49,997
- PHOTO-FINISH Qiagen Instruments
- CPC-NARROW A61B · 3 areas
- INNOV-THIN 29.7/100
- CLAIMS-DENSE 21.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Qiagen Instruments AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Qview’s 29.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Qview
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- QView Medical · this assignee 30
QView Medical · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Qview's Innovation Score is 29.7/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Qview?
Each dot is one of Qview’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Qview’s own 21.7 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Qview's grants concentrate
QView Medical Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2019. By volume, Qview sits between Quasuras, Inc. and QorTek, Inc..
Qview's three-year grant acceleration
QView Medical Inc. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at QView's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Quasuras
Quasuras, Inc.
7 patents
- Qubicaamf Europe…
Qubicaamf Europe S.P.A.
7 patents
- Quest Automated S…
Quest Automated Services, LLC
7 patents
- Quickbase
Quickbase Inc.
7 patents
- Qiagen Instruments
Qiagen Instruments AG
7 patents
- Qingdao Runbell
Qingdao Runbell Co., Ltd.
7 patents
- Qool Therapeutics
Qool Therapeutics, Inc.
7 patents
- Qortek
QorTek, Inc.
7 patents
- Qview Medical ◀
QView Medical Inc.
7 patents
What this shows QView holds 7 patents at rank #37,110, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near QView
By rank, the assignees closest to #37,110 in granted patent volume.
- Quasuras, Inc. #37,106 · 7 patents
- Qubicaamf Europe S.P.A. #37,107 · 7 patents
- Quest Automated Services, LLC #37,108 · 7 patents
- Quickbase Inc. #37,109 · 7 patents
- Qiagen Instruments AG #37,111 · 7 patents
- Qingdao Runbell Co., Ltd. #37,112 · 7 patents
- Qool Therapeutics, Inc. #37,113 · 7 patents
- QorTek, Inc. #37,114 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in QView's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Qview's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 32nd percentile higher than 32% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 42.9% |
| 2019 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2022 | 1 | 14.3% |
| 2025partial year | 1 | 14.3% |
Which technologies does QView Medical Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
QView Medical Inc.'s patent record in context - here's where to go next.
- QView Medical Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #37,151 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare QView Medical Inc. against Quasuras, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.